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Key Messages
 The efficiency of transduction of both myenteric and submucosal neurons in the mouse intestine after neonatal
systemic delivery of vectors AAV8 and AAV9 was investigated.
 AAV8 and AAV9 are equally capable of transducing the ENS, although the transduction efficiency in the
submucosal plexus is region-dependent.
 Manipulation of the ENS through gene delivery offers great potential in preclinical research and gene therapy.
Abstract
Background Despite the success of viral vector tech-
nology in the transduction of the central nervous
system in both preclinical research and gene therapy,
its potential in neurogastroenterological research
remains largely unexploited. This study asked
whether and to what extent myenteric and submu-
cosal neurons in the ileum and distal colon of the
mouse were transduced after neonatal systemic deliv-
ery of recombinant adeno-associated viral vectors
(AAVs). Methods Mice were intravenously injected
at postnatal day one with AAV pseudotypes AAV8 or
AAV9 carrying a cassette encoding enhanced green
fluorescent protein (eGFP) as a reporter under the
control of a cytomegalovirus promoter. At postnatal
day 35, transduction of the myenteric and submucosal
plexuses of the ileum and distal colon was evaluated
in whole-mount preparations, using immunohisto-
chemistry to neurochemically identify transduced
enteric neurons. Key Results The pseudotypes AAV8
and AAV9 showed equal potential in transducing the
enteric nervous system (ENS), with 25–30% of the
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neurons expressing eGFP. However, the percentage of
eGFP-expressing colonic submucosal neurons was
significantly lower. Neurochemical analysis showed
that all enteric neuron subtypes, but not glia,
expressed the reporter protein. Intrinsic sensory neu-
rons were most efficiently transduced as nearly 80% of
calcitonin gene-related peptide-positive neurons
expressed the transgene. Conclusions & Inferences
The pseudotypes AAV8 and AAV9 can be employed
for gene delivery to both the myenteric and the
submucosal plexus, although the transduction effi-
ciency in the latter is region-dependent. These findings
open perspectives for novel preclinical applications
aimed at manipulating and imaging the ENS in the
short term, and in gene therapy in the longer term.
Keywords AAV, enteric nervous system, myenteric
plexus, submucosal plexus, viral transfection.
INTRODUCTION
Viral vector technology in gene delivery to the enteric
nervous system (ENS) is poorly exploited, despite
important merits of viral vectors in the transduction
of the central nervous system in both preclinical
research and gene therapy.1–3 Recombinant adeno-
associated viruses vectors (AAVs) belong to the most
promising candidate vector systems in gene therapy
and preclinical research1,3, but hitherto little is known
about the transduction efficiency of the ENS by AAV.
Rahim et al.4 and Schuster et al.5 have preliminarily
indicated transduction of the myenteric plexus of the
mouse with AAV9, and a more recent paper by
Gombash et al.6 has detailed myenteric plexus trans-
duction by self-complementary AAV9 in neonate and
juvenile mice with green fluorescent protein (GFP)
being expressed under a chicken-b-actin/cytomegalo-
virus (CB) hybrid promoter. However, data on submu-
cosal plexus transduction are currently lacking, as is
quantification of the neuronal subtypes transduced by
AAV. Here, we further explored the transduction of the
ENS in the ileum and colon of the mouse by single
stranded AAV8 and AAV9 encoding GFP driven by the
immediately early human cytomegalovirus (CMV)
promoter after neonatal i.v. injection.
MATERIALS AND METHODS
Recombinant AAV vector preparation
Vector production and purification were performed at the Leuven
Viral Vector Core as previously described.7 Adeno-associated viral
vectors encoding enhanced GFP (eGFP) reporter protein driven by
the CMV promoter were packaged in an AAV8- or AAV9-capsid.
Briefly, following triple transient transfection (pAdvDeltaF6 [ade-
noviral helper plasmid], pAAV2/8 or pAAV2/9 [AAV serotypes],
pAAV-TF CMV-eGFP-T2A-fLuc [AAV transfer plasmid encoding
eGFP and fLuc reporters driven by a CMV promoter7] in a 1 : 1 : 1
Marker
AAV8 AAV9
Ileum Distal colon Ileum Distal colon
Marker+ GFP+ Marker+ GFP+ Marker+ GFP+ Marker+ GFP+
HuC/D (MP) 2950 804 2533 761 2923 704 1839 394
HuC/D (SMP) 752 226 588 65 395 96 234 11
CGRP (MP) 349 867 208 378 312 762 175 660
CB (MP) 152 563 120 300 93 472 111 599
CRT (MP) 285 351 384 441 239 234 317 319
CRT (SMP) 386 96 nd nd 414 127 nd nd
nNOS (MP) 332 358 739 416 472 537 898 636
VIP (SMP) 245 159 nd nd 182 88 nd nd
Numbers are the total of counted cells from three (neurochemical coding) or four (HuC/D stains)
animals. For statistical analysis an animal was considered the experimental unit and the
countings were averaged per animal. MP, myenteric plexus; SMP, submucosal plexus; AAV,
adeno-associated viral vectors; GFP, green fluorescent protein; CGRP, calcitonin gene-related
peptide; CRT, calretinin; VIP, vasoactive intestinal peptide.
Table 1 Total number of counted neurons
in the quantification experiments
Figure 1 Transduction of myenteric and submucosal neurons of ileum and colon. (A and B) Expression of the GFP transgene was limited to enteric
ganglia (arrows) and neuronal fibers (arrowheads) (C) Transduction allows some axons to be traced along internodal strands, as exemplified by this
stacked confocal image (z = 19 lm) with an axon extending into the longitudinal muscle layer (arrowhead). (D–F) Transduction of myenteric ganglia
of the colon (D) and ileum (E and F). Note the lamellar dendrites on the perikaryum in (F), indicative of a Dogiel type I neuron (arrowhead). (G) GFP-
expressing submucosal neurons were rare in the colon, but GFP-positive fibers could readily be observed. (H) Submucosal ganglia of the ileum showed
numerous transduced neurons. (I and J) Quantification of the number of transduced neurons showed transduction efficiency to be independent of
AAV serotype, but the colonic submucosal neurons were significantly less transduced than ileal submucosal neurons. Scale bars 35 lm; MP,
myenteric plexus; SMP, submucosal plexus; AAV, adeno-associated virus.
© 2015 The Authors.
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ratio) into HEK293T cells using 25 kDa linear polyethylenimine,
viral vector particles were collected from the supernatant and
concentrated using tangential flow filtration and iodixanol gradi-
ent purification. Gradient fractions of concentrated AAV particles
were stored at 80 °C. Titers for AAV stocks were controlled by
qPCR analysis to determine AAV genome copies (GC/mL) and
silver-stained sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis.
Injection procedure
Following hypothermic anesthesia, the respective AAV vectors
were administered to C57BL/6 mouse pups on postnatal day one
by injection into the superficial temporal vein using a 33G needle
(Hamilton, Reno, NV, USA). 20 lL of AAV vector with
1.09 9 1012 GC/mL AAV8 or 1.19 9 1012 GC/mL AAV9 was
administered. Eight animals from two different litters were
injected for each vector. At 35 days of age the injected mice were
sacrificed. All animal experiments were approved by the Ethical
Committee for Animals of the University of Antwerp and were in
line with EU directive 2010/63/EU.
Immunohistochemistry
The ileum and distal colon were fixed in 4% paraformaldehyde.
Whole-mounts and cryosections were prepared as described
before.8,9 Tissue samples were preincubated in 0.1 M phosphate-
buffered saline (PBS; pH 7.4) with 0.05% thimerosal, 10% normal
horse serum, and 1% triton X-100. In case of anti-HuC/D staining
this was supplemented with Mouse-On-Mouse blocking reagent
(Vector Labs, Burlingame, CA, USA). Tissue was incubated over-
night with one of the following primary antibodies; mouse anti-
HuC/D (1 : 500; Thermo Fisher Scientific, Waltham, MA, USA;
clone 16A11), goat anti-neuronal nitric oxide synthase (nNOS;
1 : 1000; Abcam, Cambridge, MA, USA; ab1376), goat anti-cal-
bindin (CALB; 1 : 200; SantaCruzBiotechnology,Dallas, TX,USA;
sc-7691), goat anti-calretinin (CRT; 1 : 10 000; Swant, Marly,
Switzerland; CG1), sheep anti-tyrosine hydroxylase (TH; 1 : 500;
Novus Biologicals, Littleton, CO, USA; NB300-110), goat anti-va-
soactive intestinal peptide (VIP; 1 : 100; Santa Cruz Biotechnology
sc-7841), rabbit anti-S100B (1 : 5000; Dako, Glostrup, Denmark;
Z0311), goat anti-calcitonin gene-related peptide (CGRP; 1 : 5000;
Abcam ab36001), rabbit anti-glial fibrillary acidic protein (GFAP;
1 : 500; Dako Z0334), or rabbit anti-GFP (1 : 500; Abcam ab290).
After rinsing with PBS, tissues were incubated with corresponding
Cy3-conjugated secondary IgG antibodies raised in donkey (1 : 800;
Jackson Immunoresearch, West Grove, PA, USA). Antibodies were
validated by appropriate negative control experiments as detailed
previously.10,11 In case of VIP and CGRP immunostaining for
quantification, axonal transport was blocked with colchicine in
organotypic culture enhancing the perikaryal localization of these
neuropeptides. The culture medium was composed of 10% FCS,
100 U/mL penicillin–streptomycin, 50 lg/mL gentamycin, 2.5 lg/
mL amphotericin B, 1 lM nifedipine, 0.1 mg/mL colchicine in
DMEM:F12 (LifeTechnologies). Imageswere acquired using aZeiss
(Oberkochen, Germany) Axiophot fluorescence microscope
equipped with an Olympus (Tokyo, Japan) DP70 digital camera
(cryosections) or a Zeiss LSM510 confocal microscope (whole-
mounts).
Quantification & statistical analysis
Whole-mounts from at least three animals were counted (exact n is
indicated in the results section). Randomly chosen fields of view
amounted to an imaged area of 1.5 mm2 per whole-mount. The
number of counted neurons is listed in Table 1. Images were
manually countedusing ImageJ anddatawere further analyzedwith
Graphpad (La Jolla, CA, USA) Prism 6. Data are represented as
mean  SEM.The influence of the factors ‘intestinal region’ (ileum
or colon) and ‘AAV serotype’ (AAV8 or AAV9) on the number of
transduced (GFP-positive) enteric neurons (HuC/D-positive) was
statistically evaluated with two-way ANOVA at a p = 0.05 signifi-
cance level.
RESULTS
Transduction of the myenteric and submucosal
plexuses by AAV8 and AAV9
Green fluorescent protein fluorescence was limited to
enteric ganglia and interganglionic connecting nerve
strands, with an identical GFP pattern for AAV8 or
AAV9 (Fig. 1A and B). Endogenous GFP fluorescence
coincided with anti-GFP immunoreactivity in the
whole-mounts, indicating that endogenous GFP fluo-
rescence had not suffered from fixation or staining
procedures (data not shown). Adeno-associated viral
vector-transduced GFP fluorescence allowed morpho-
logical classification into Dogiel subtypes and tracing
of individual axons along internodal strands in whole-
mount preparations (Fig. 1C). The pseudotypes, AAV8
and AAV9, were equally potent in transducing the ileal
and colonic enteric plexuses (Table 2).
The myenteric plexus of both regions was trans-
duced to the same extent, with 25–30% of the HuC/D
immunoreactive myenteric neurons coexpressing GFP
(Fig. 1D–F, Table 2). However, a significantly lower
number of submucosal neurons showed GFP fluores-
cence in the colon (p = 0.0012, two-way ANOVA),
although GFP-fluorescent nerve fibers could be readily
observed (Fig. 1G and H, Table 2).
Transduction of the neurochemical classes of
enteric neurons by AAV8 and AAV9
All neuronal subtypes were susceptible to AAV trans-
duction, as revealed by neurochemical marker staining
(Fig. 2, Table 3). Given the low transduction of the
colonic submucosal plexus, subtypes were not quanti-
fied for this specific region. The highest transduction
efficiency was observed in the CGRP- or CALB-
immunoreactive myenteric neurons, with 50 to almost
80% of these neurons expressing GFP. In the other
subpopulations the transduced proportion remained
closer to the 20–30% range. About 50 ganglia from two
animals per AAV serotype were evaluated for the glial
cell markers GFAP or S100. None of them yielded any
GFP signal in enteric glial cells (Fig. 2I and J).
© 2015 The Authors.
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DISCUSSION
We demonstrate that AAV8 and AAV9, carrying GFP
under control of a CMV promoter, efficiently transduce
myenteric and submucosal neurons of the mouse small
and large intestine when injected i.v. in P1 neonates.
This is in line with Gombash et al., who recently
employedAAVvectors containinga self-complementary
Table 2 Transduction of enteric neurons by AAV8 or AAV9
GFP+/HuC-D+, mean %  SEM
(n = 4 animals)
AAV8 AAV9
Ileum Colon Ileum Colon
Myenteric plexus 26  3 29  4 24  3 22  3
Submucosal plexus 28  5 12  5 23  3 5  2
See Table 1 for abbreviations.
A A2
C1
E
G H I J
C2
F1 F2 F3
D1 D2
A3 B
Figure 2 Neurochemical classification of transduced myenteric and submucosal neurons. Neurons immunostained for (A) calcitonin gene-related
peptide, (B) calbindin, (C and D) calretinin, (E) neuronal nitric oxide synthase, (D) vasoactive intestinal peptide, or (F and G) tyrosine hydroxylase all
were susceptible to transduction with AAV8 and AAV9. (H and I) S100 (H) or glial fibrillary acidic protein (I) immunoreactive glial cells did not
express the transgene. Scale bars 35 lm; MP, myenteric plexus; SMP, submucosal plexus; AAV, adeno-associated virus.
© 2015 The Authors.
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genome encoding GFP under a CB promoter for the
transduction of the myenteric plexus.6 Hence, the rate-
limiting second-strand synthesis required in the case of
single stranded AAV, does not affect the construct’s
expression in enteric neurons. The advantage of using
single stranded AAV vectors lies in the longer construct
length (4.7 kb) they can hold compared to self-comple-
mentary AAV (about 2.4 kb). Both vectors were equally
potent, in contrast to the lower transduction efficiency
of AAV8 compared to AAV9 observed in the adult rat
colon after intramural injection of AAV-GFP under the
CB promoter.12 It should be noted that the systemic
distribution of intravenously injected AAV is not
limited to the ENS.4,5,13 In the light of gene therapy,
future efforts should evaluate specificity-enhancing
strategies such as ENS-specific promotors, AAV with
modified glycan binding ability or micro-RNAs.14,15
Enteric glia lacked transgene expression, but these cells
could be targeted with other AAV serotypes or GFAP
promotor-driven constructs, as these strategies have
been proven successful in earlier work.6,12
To our knowledge, the paper by Gombash et al. is
the only other work that neurochemically identifies
AAV-transduced myenteric neurons of the mouse.6
Our results further revealed significantly lower trans-
duction efficiency in the submucosal plexus of the
distal colon, compared to the ileum. The reason for this
difference is not clear: transduction efficiency can be
affected due to anatomical constraints such as villous
fenestrated capillaries in the ileum facilitating viral
vector access, or pertain to more complex physiological
differences such as regional differences in immune
response.16 Alternatively, even though the CMV pro-
moter can be considered as an ubiquitous promoter,
lower CMV-driven expression in the submucosal
plexus of the distal colon may also account for this
difference.
Gombash et al. did not quantify transduction in
neurochemically coded neurons, but did report that
GFP expression was absent in VIP- or nNOS-positive
myenteric neurons after AAV9 transduction, which
contrasts with our observations showing nearly
20% of inhibitory (nitrergic) motor neurons express-
ing GFP.6 The proportion of transduced intrinsic
sensory neurons (CGRP- or CALB-immunoreactive)
was substantially larger compared to inhibitory motor
neurons, but transduction of the latter was not
absent. Moreover, submucosal VIPergic neurons were
readily transduced in our study. These discrepant
observations might pertain to differences in the
promoter (CB vs CMV), although the genetic back-
ground of the mice (FVB vs C57BL/6) may also play a
role.
This study strengthens the validity of AAV vectors
in transducing the myenteric plexus of the mouse and
expands AAV application to the submucosal plexus.
This application has important preclinical merits on
the short term: Cre-inducible transgene-cassettes com-
bined with Cre-expressing mouse lines enables selec-
tive manipulation of enteric neurons in vivo. For
example, transduction of genetically encoded calcium
sensors or channel rhodopsins allows selective imaging
and manipulation in live cell experiments. The fact
that transduction can be executed in the neonatal time
window is important for studying postnatal ENS
development during the weaning period. In the longer
term, genetic therapies targeting the ENS in clinical
applications can be evaluated.
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Table 3 Transduction in neurochemically stained enteric neurons
Mean %  SEM
(n = 3)
AAV8 AAV9
Ileum Distal colon Ileum Distal colon
GFP+/
marker+
Marker+/
GFP+
GFP+/
marker+
Marker+/
GFP+
GFP+/
marker+
Marker+/
GFP+
GFP+/
marker+
Marker+/
GFP+
CGRP (MP) 78  1 31  2 60  2 31  1 77  5 32  4 57  11 18  4
CB (MP) 54  6 16  2 49  6 19  0 61  5 11  2 70  2 10  1
CRT (MP) 33  5 27  3 37  2 31  3 27  1 26  3 40  18 30  6
CRT (SMP) 14  4 50  12 nd nd 18  1 54  1 nd nd
nNOS (MP) 17  2 16  1 15  2 31  5 21  7 17  2 16  4 22  3
VIP (SMP) 32  5 45  7 nd nd 52  5 73  3 nd nd
In the myenteric plexus CGRP is expressed in intrinsic primary afferent neurons (IPANs); CB marks a subpopulation of IPANs; nNOS is mainly found
in inhibitory motor neurons; CRT marks IPANs, excitatory motor neurons, and a subpopulation of interneurons. In the submucosal plexus CRT and
VIP stain vasodilator and secretomotor neurons. A detailed description of the different neurochemical classes in the mouse enteric nervous system
can be found in references (17–19). See Table 1 for abbreviations.
© 2015 The Authors.
Neurogastroenterology & Motility Published by John Wiley & Sons Ltd.
304
R. Buckinx et al. Neurogastroenterology and Motility
FUNDING
This study was supported by FWO grant G019314N to JPT and RB
and MRC grant G1000709 to SW.
DISCLOSURE
No competing interest declared.
AUTHOR CONTRIBUTION
RB designed the study, obtained funding, performed experiments,
analyzed data, and wrote the paper; SVR performed experiments;
RG contributed the AAV vectors; SW participated in study design
and provided technical and scientific support for the study; JPT
designed the study, obtained funding, and wrote the paper. All
authors critically reviewed the manuscript.
REFERENCES
1 Lentz TB, Gray SJ, Samulski RJ. Viral
vectors for gene delivery to the central
nervous system. Neurobiol Dis 2012;
48: 179–88.
2 Murlidharan G, Samulski RJ, Asokan
A. Biology of adeno-associated viral
vectors in the central nervous system.
Front Mol Neurosci 2014; 7: 1–9.
3 McCown TJ. Adeno-Associated Virus
(AAV) Vectors in the CNS. Curr Gene
Ther 2011; 11: 181–8.
4 Rahim A, Wong AMS, Hoefer K,
Buckley SMK, Mattar CN, Cheng
SH, Chan JKY, Cooper JD et al. Intra-
venous administration of AAV2/9 to
the fetal and neonatal mouse leads to
differential targeting of CNS cell
types and extensive transduction of
the nervous system. FASEB J 2011;
25: 3505–18.
5 Schuster DJ, Dykstra JA, Riedl MS,
Kitto KF, Belur LR, McIvor RS, Elde
RP, Fairbanks CA et al. Biodistribu-
tion of adeno-associated virus sero-
type 9 (AAV9) vector after intrathecal
and intravenous delivery in mouse.
Front Neuroanat 2014; 8: 42.
6 Gombash SE, Cowley CJ, Fitzgerald
JA, Hall JCE, Mueller C, Christofi FL,
Foust KD. Intravenous AAV9 effi-
ciently transduces myenteric neurons
in neonate and juvenile mice. Front
Mol Neurosci 2014; 7: 81.
7 Van der Perren A, Toelen J, Carlon M,
Van den Haute C, Coun F, Heeman B,
Reumers V, Vandenberghe LH et al.
Efficient and stable transduction of
dopaminergic neurons in rat substan-
tia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2,
2/7, 2/8 and 2/9. Gene Ther 2011; 18:
517–27.
8 Buckinx R, Bagyanszki M, Avula LR,
Adriaensen D, Van Nassauw L, Tim-
mermans J-P. Expression of corti-
cotropin-releasing factor and
urocortins in the normal and Schisto-
soma mansoni-infected mouse ileum.
Cell Tissue Res 2014; 359: 453–63.
9 Avula LR, Buckinx R, Alpaerts K,
Costagliola A, Adriaensen D, Van
Nassauw L, Timmermans J-P. The
effect of inflammation on the expres-
sion and distribution of the MAS-
related gene receptors MrgE and MrgF
in the murine ileum. Histochem Cell
Biol 2011; 136: 569–85.
10 Van Op den Bosch J, van Nassauw L,
Lantermann K, van Marck E, Tim-
mermans J-P. Effect of intestinal
inflammation on the cell-specific
expression of somatostatin receptor
subtypes in the murine ileum. Neu-
rogastroenterol Motil 2007; 19: 596–
606.
11 Buckinx R, Bagyanszki M, Avula LR,
Adriaensen D, Van Nassauw L, Tim-
mermans J-P. Expression of corti-
cotropin-releasing factor and
urocortins in the normal and Schis-
tosoma mansoni-infected mouse
ileum. Cell Tissue Res 2015; 359:
453–63.
12 Benskey MJ, Kuhn NC, Galligan JJ,
Garcia J, Boye SE, Hauswirth WW,
Mueller C, Boye SL et al. Targeted
gene delivery to the enteric nervous
system using AAV: a comparison
across serotypes and capsid mutants.
Mol Ther 2015; 23: 488–500.
13 Mattar CN, Wong AMS, Hoefer K,
Alonso-Ferrero ME, Buckley SMK,
Howe SJ, Cooper JD, Waddington SN
et al. Systemic gene delivery follow-
ing intravenous administration of
AAV9 to fetal and neonatal mice
and late-gestation nonhuman pri-
mates. FASEB J 2015; 29: 3876–88.
14 Shen S, Bryant KD, Sun J, Brown SM,
Troupes A, Pulicherla N, Asokan A.
Glycan binding avidity determines
the systemic fate of adeno-associated
virus type 9. J Virol 2012; 86: 10408–
17.
15 Brown BD, Gentner B, Cantore A,
Colleoni S, Amendola M, Zingale A,
Baccarini A, Lazzari G et al. Endoge-
nous microRNA can be broadly
exploited to regulate transgene
expression according to tissue, lin-
eage and differentiation state. Nat
Biotechnol 2007; 25: 1457–67.
16 Mowat AM, Agace WW. Regional
specialization within the intestinal
immune system. Nat Rev Immunol
2014; 14: 667–85.
17 Sang Q, Young HM. Chemical coding
of neurons in the myenteric plexus
and external muscle of the small and
large intestine of the mouse. Cell
Tissue Res 1996; 284: 39–53.
18 Qu Z-D, Thacker M, Castelucci P,
Bagyanszki M, Epstein ML, Furness
JB. Immunohistochemical analysis of
neuron types in the mouse small
intestine. Cell Tissue Res 2008; 334:
147–61.
19 Mongardi Fantaguzzi C, Thacker M,
Chiocchetti R, Furness JB. Identifica-
tion of neuron types in the submu-
cosal ganglia of the mouse ileum.
Cell Tissue Res 2009; 336: 179–89.
© 2015 The Authors.
Neurogastroenterology & Motility Published by John Wiley & Sons Ltd.
305
Volume 28, Number 2, February 2016 AAV transduces submucosal & myenteric neurons
